Home > Gastroenterology > UEGW 2019 > Inflammatory Bowel Diseases > Ileal microbiota predict recurrence in CD patients after resection

Ileal microbiota predict recurrence in CD patients after resection

Conference
UEGW 2019
Trial
Cohort study, REMIND

A new study, led by researchers from Saint Antoine Hospital, in France, reveals that ileal mucosa-associated microbiota may help predict recurrence in patients with CD after ileocecal resection [1].

Recurrence of inflammatory lesions is frequent in patients undergoing ileal resection for Crohn’s disease (CD), although there is not a single clinical risk factor that can be used as a perfect predictor of early postoperative endoscopic recurrence. The researchers of this study sought a microbiotic biomarker to predict recurrence. To this end they catalogued the ileal mucosa-associated microbiota by using ribosomal 16S sequencing at the time of surgery and/or at the time of postoperative endoscopic evaluation (about 6 to 12 months after surgery) in 201 patients from 9 centres in the prospective REMIND cohort. Not surprisingly, antibiotics treatment within one month before surgery had a dramatic impa...



please login to read the entire article:


You need to register to read the entire article, please do so now.





Posted on